689 results on '"Ukimura A"'
Search Results
2. Plasma circulating tumor <scp>DNA</scp> profiling in patients with chemo‐refractory germ cell tumors
3. Focal therapy of localized prostate cancer
4. Preliminary study of the safety of acrinol in probe‐based confocal laser endomicroscopy during transurethral resection of bladder tumors
5. Increasing rectum–prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer
6. Novel device for dividing core needle biopsy specimens to provide paired mirror image-like tissues for genetic and pathological tests
7. A big data-based prediction model for prostate cancer incidence in Japanese men
8. Supplementary Figure S2: Expressions of DR5 mRNA and cell-surface DR5 are different between two bladder cancer cell lines. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
9. Suuplementary Figure S3: Combined treatment with OBP-801 and celecoxib induces binding of caspase-8 to DR5, and Bim expression in bladder cancer cells. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
10. Supplementary Figure S4: The combination induces apoptosis in a TRAIL-independent manner in UM-UC-11 cells. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
11. Supplementary Figure S1: Combined treatment with OBP-801 and celecoxib reduces FLIP and survivin expression at mRNA level. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
12. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019–2020: General view of the pathogens' antibacterial susceptibility
13. MP73-19 FOCAL CRYOABLATION VS FOCAL HIGH INTENSITY FOCUSED ULTRASOUND FOR INTERMEDIATE AND HIGH-RISK PROSTATE CANCER
14. PD13-13 A FULLY AUTOMATED ARTIFICIAL INTELLIGENCE SUPPORT SYSTEM FOR URINE CYTOLOGY: MULTI-CENTER EXTERNAL VALIDATION STUDY
15. Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society
16. Microwave focal therapy of prostate cancer: a non‐clinical study and exploratory clinical trial
17. Bone marrow metastasis in a patient with non‐seminomatous testicular germ cell tumor
18. TGF-β inhibitor treatment of H₂O₂-induced cystitis models provide molecular mechanism for elucidating interstitial cystitis/painful bladder syndrome patients
19. Patient-reported Satisfaction and Regret Following Focal Therapy for Prostate Cancer: A Prospective Multicenter Evaluation
20. Development of novel artifact-less imaging-guidance marker for MRI, CT, and Ultrasound imaging-modalities aiming for organ-preserving therapies of prostate cancer
21. Artificial intelligence trained with integration of multiparametric MR‐US imaging data and fusion biopsy trajectory‐proven pathology data for 3D prediction of prostate cancer: A proof‐of‐concept study
22. Double renal cell carcinoma with histological type of clear cell carcinoma and papillary carcinoma in the same kidney concurrently treated with robot‐assisted partial nephrectomy
23. Virtual reality of three-dimensional surgical field for surgical planning and intraoperative management
24. Multiple Cardiovascular Diseases or Risk Factors Increase the Severity of Coronavirus Disease 2019
25. Health-Related Quality of Life in Testicular Cancer Survivors in Japan: A Multi-Institutional, Cross-Sectional Study Using the EORTC QLQ-TC26
26. Young Healthy Patient With Severe COVID-19 and Fulminant Community-Acquired Pseudomonas aeruginosa Pneumonia: A Case Report
27. Role of hydrogel spacer to protect the rectum from thermal injury in focal therapy of prostate cancer: Preclinical study in cadaver model
28. A Prospective Study Regarding the Efficacy and Safety of the BNT162b2 Vaccine in Patients With Solid Malignancies Undergoing Systemic Chemotherapy
29. Novel surgical technique for orchiopexy of intra-abdominal testis
30. Future expectations for prediction of congenital malformations by classification and regression tree analysis by ultrasonography
31. Fertility and reproductive technology use in testicular cancer survivors in Japan: A multi‐institutional, cross‐sectional study
32. Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients
33. Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy, and Chemotherapy
34. Efficacy of tadalafil on symptom-specific bother in men with lower urinary tract symptoms
35. Editorial Comment to Genomic landscape of treatment-naïve urological cancers using next-generation sequencing-based panel test in the Japanese population
36. Detection of relatively poor but definitive blood supply in prostate stromal sarcoma using transrectal ultrasonography with superb microvascular imaging
37. MP55-08 HIGH INTENSITY FOCUSED ULTRASOUND AND CRYOABLATION FOCAL THERAPY FOR INTERMEDIATE RISK PROSTATE CANCER: ONCOLOGIC AND FUNCTIONAL OUTCOMES
38. Association of financial toxicity with quality of life in testicular cancer survivors
39. PCA3 controls chromatin organization and p53 signal activation by regulating LAP2α-lamin A complexes
40. Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up
41. Time-course changes in multiparametric magnetic resonance imaging following focal cryotherapy for localized prostate cancer: Initial experience
42. Evaluation of the safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex: The Cryo-TSC
43. Phase I/II study of multipeptide cancer vaccine IMA901 in Japanese patients with advanced renal cell cancer with long-term follow up
44. Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly
45. New modified technique of hydrogel spacer implantation for prostate cancer: a novel method for separation at the prostate apex level under real-time ultrasound guidance
46. A real-world study on the safety of the extended dosing schedule for nivolumab and pembrolizumab in patients with solid tumors
47. Phase I/II study of multipeptide cancer vaccine IMA901 after single-dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long-term follow up
48. Can We Avoid a Systematic Biopsy in Men with PI-RADS® 5? Reply
49. Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis
50. Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.